Hans Edgar Bishop
CIK 1480212 · CEO & President · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$82.08M
Companies
6
Total Filings
71
Lifetime Open-Market Net
-$34.48M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANA | Director | 5,848,503 | $2.68 | $15.67M | $0 | 26 | 2026-06-05 |
| LYEL | Director | 4,685,614 | $13.50 | $63.26M | $0 | 7 | 2024-06-17 |
| A | Director | 24,226 | $129.84 | $3.15M | $0 | 9 | 2024-03-19 |
| CELGENE CORP /DE/ (CELGZ) Delisted | Director | 0 | — | — | $0 | 3 | 2019-11-22 |
| Juno Therapeutics, Inc. (JUNO) Delisted | CEO & President | 135,452 | — | — | -$34.48M | 17 | 2018-03-07 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 93,350 | — | — | $0 | 3 | 2014-02-14 |
Recent Filings · Page 4 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-21 | A | Grant (A) | +2,582 | $353.3K | EDGAR |
| 2022-02-25 | LYEL | Exer (M) | +993,428 | $99.3K | EDGAR |
| 2021-06-23 | LYEL | Conv (C) | +546,806 | $0 | EDGAR |
| 2021-03-22 | A | Grant (A) | +2,672 | $324.9K | EDGAR |
| 2021-02-18 | SANA | Grant (A) | — | $0 | EDGAR |
| 2021-02-10 | SANA | Conv (C) | +2,031,250 | $0 | EDGAR |
| 2021-02-05 | SANA | Grant (A) | — | $0 | EDGAR |
| 2020-08-05 | A | Grant (A) | +177 | $16.6K | EDGAR |
| 2020-04-21 | A | Grant (A) | +4,108 | $299.9K | EDGAR |
| 2019-11-22 | CELGENE CORP /DE/ (CELGZ) Delisted | Disp (D) | −23,088 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.